Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

L PERRIGO CO

  • FDA Approval
  • March 19, 2024, 09:01 UTC
  • 33
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

L PERRIGO CO

  • FDA Approval
  • March 19, 2024, 09:01 UTC
  • 33
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

ZYDUS

  • FDA Approval
  • March 19, 2024, 04:21 UTC
  • 35
  • 0 comments

FDA approve FINASTERIDE; TADALAFIL

Comment Full text

JANSSEN PRODS

  • FDA Approval
  • March 18, 2024, 18:08 UTC
  • 36
  • 0 comments

FDA approve RILPIVIRINE

Comment Full text

BIOFRONTERA

  • FDA Approval
  • March 18, 2024, 17:59 UTC
  • 36
  • 0 comments

FDA approve AMINOLEVULINIC ACID HYDROCHLORIDE

Comment Full text

ZYDUS

  • FDA Approval
  • March 18, 2024, 08:52 UTC
  • 30
  • 0 comments

FDA approve CHLORPROMAZINE HYDROCHLORIDE

Comment Full text

PERRIGO R AND D

  • FDA Approval
  • March 18, 2024, 08:52 UTC
  • 32
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

PERRIGO R AND D

  • FDA Approval
  • March 18, 2024, 08:52 UTC
  • 30
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

PERRIGO R AND D

  • FDA Approval
  • March 18, 2024, 08:52 UTC
  • 26
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

PERRIGO R AND D

  • FDA Approval
  • March 18, 2024, 08:52 UTC
  • 29
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text
  • Previous
  • 526
  • 527
  • 528
  • 529
  • 530
  • Next

Search

News categories

  • Technical Exchange News(11754)
  • Event(4289)
  • SEC News(235844)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(143280)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin